Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143428 |
| CAS No | NA |
| Mol.F. | C19H10Cl2I2N2O4 |
| Mol.Wt. | 655.01 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143429 |
| CAS No | NA |
| Mol.F. | C28H34N8O |
| Mol.Wt. | 498.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143430 |
| CAS No | NA |
| Mol.F. | C28H31N10O |
| Mol.Wt. | 523.62 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143431 |
| CAS No | NA |
| Mol.F. | C15H18N6O |
| Mol.Wt. | 298.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143432 |
| CAS No | NA |
| Mol.F. | C19H27N6O |
| Mol.Wt. | 355.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143433 |
| CAS No | NA |
| Mol.F. | C13H13N5O2 |
| Mol.Wt. | 271.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143434 |
| CAS No | NA |
| Mol.F. | C13H12ClN5O |
| Mol.Wt. | 289.72 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143435 |
| CAS No | NA |
| Mol.F. | C15H18N6O2 |
| Mol.Wt. | 314.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143436 |
| CAS No | NA |
| Mol.F. | C9H10N6O |
| Mol.Wt. | 218.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143437 |
| CAS No | NA |
| Mol.F. | C15H21N7O |
| Mol.Wt. | 315.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143438 |
| CAS No | NA |
| Mol.F. | C9H10N6O4S |
| Mol.Wt. | 298.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143439 |
| CAS No | NA |
| Mol.F. | C15H18N6O |
| Mol.Wt. | 298.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143440 |
| CAS No | NA |
| Mol.F. | C19H27N5O2Si |
| Mol.Wt. | 385.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143441 |
| CAS No | NA |
| Mol.F. | C17H17N7O |
| Mol.Wt. | 335.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143442 |
| CAS No | NA |
| Mol.F. | C17H18N6O3 |
| Mol.Wt. | 354.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143443 |
| CAS No | NA |
| Mol.F. | C17H17N7O |
| Mol.Wt. | 335.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |